Učitavanje...
NmeCas9 is an intrinsically high-fidelity genome-editing platform
BACKGROUND: The development of CRISPR genome editing has transformed biomedical research. Most applications reported thus far rely upon the Cas9 protein from Streptococcus pyogenes SF370 (SpyCas9). With many RNA guides, wildtype SpyCas9 can induce significant levels of unintended mutations at near-c...
Spremljeno u:
| Izdano u: | Genome Biol |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282386/ https://ncbi.nlm.nih.gov/pubmed/30518407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13059-018-1591-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|